The University of California, Davis received a $1,801,179 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on April 15, 2025, supports advanced biomedical research to investigate the contribution of bone mass and fracture to bone metastasis in prostate cancer. As a prominent research university, UC Davis leverages its extensive scientific expertise and research...
The University of California, Davis was awarded a $1,177,500 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year grant will fund research to target a key tumor plasticity driver in lethal prostate cancer. Through August 2021 to July 2024, UC Davis researchers will investigate medical solutions for prostate cancer on the cellular level with the aim of transforming patient care and outcomes. The...
The University of California, Davis was awarded a $1,446,250 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on "THERAPEUTIC TARGETING OF A NOVEL TUMOR-INTRINSIC SIGNALING PATHWAY FOR LETHAL PROSTATE CANCER." The award period is from August 1, 2023 to July 31, 2026. UC Davis will leverage its expertise in medical research to investigate potential medical solutions relevant to the...
The University of California, Davis (UC Davis) was awarded a $321,981 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) to support research on "Sensory Processing Contributions to Emotion Dysregulation and Internalizing Problems in Autism". The grant, which runs from April 1, 2025 to March 31, 2027, will fund advanced biomedical research aimed at transforming healthcare for military service members and the...
The University of California, Davis was awarded a $483,000 Project Grant from the Department of the Army's Military Medical Research and Development program (CFDA 12.420) to conduct research on "TARGETING DRUG-TOLERANT PERSISTER CELLS IN OVARIAN CANCER." The award period is from April 1, 2024 to March 31, 2026. The objective of this research project is to develop new treatments for ovarian cancer by targeting drug-tolerant persister cells. As a major public research university, UC...
This federal Project Grant award, totaling $1,163,420.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to the University of California, Davis. The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The research aims to investigate functional and phenotypic metabolic transitions governing disease state in clear cell renal cell...
The University of California, Davis was awarded a $1,446,009 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to target CD200/CD200R signaling as a novel strategy for treating therapy-resistant prostate cancer. The grant, awarded July 1, 2023 and set to be completed by June 30, 2026, will support research into medical solutions for prostate cancer that remains unresponsive to standard treatments by...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, in the amount of $442,750.00, supports research to determine the role of histone lactylation in post-traumatic osteoarthritis and arthritic pain. The award was made to the University of California, Davis, a prominent public research university with extensive expertise in medical research, on February 1, 2025, with a planned completion date of January 31,...
The University of California, Davis (UC Davis) has been awarded a $1,000,000 federal Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) for the "THE GOOD LIFE HEALTHY AGING PROGRAM TO PREVENT COGNITIVE IMPAIRMENT IN DIVERSE VETERAN COMMUNITIES: AN EMBEDDED PRAGMATIC CLINICAL TRIAL". The grant, which runs from May 1, 2024 to April 30, 2027, will fund research aimed at improving health outcomes for...
This federal Project Grant award of $1,298,836.00 from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of California, Davis (UC Davis) to investigate toxic products of combustion in burn and smoke inhalation injuries. The research aims to transform healthcare for military service members and the general public through innovative and impactful studies spanning basic, applied, and translational...